Hasil Pencarian - Joseph Markowitz

  • Menampilkan 1 - 12 hasil dari 12
Perbaiki Hasil
  1. 1
    Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy

    Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy oleh Saurabh K. Garg, Matthew J. Ott, A. G. M. Mostofa, Zhihua Chen, Y. Ann Chen, Jodi Kroeger, Biwei Cao, Adam W. Mailloux, Alisha Agrawal, Braydon J. Schaible, Amod Sarnaik, Amod Sarnaik, Jeffrey S. Weber, Anders E. Berglund, James J. Mulé, James J. Mulé, Joseph Markowitz, Joseph Markowitz, Joseph Markowitz

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Age-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters

    Age-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters oleh Seok Kyu eKang, Geoffrey Joseph Markowitz, Shin Tae eKim, Michael Van Doren Johnston, Shilpa Dattatray Kadam

    Diterbitkan 2015-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma

    A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma oleh Joseph Markowitz, Ragini Kudchadkar, Jeffrey S. Weber, Zeynep Eroglu, Andrew S. Brohl, Nikhil I. Khushalani, Ram Thapa, Y. Ann Chen

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy

    235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy oleh Joseph Markowitz, Anders Berglund, Saurabh Garg, Eric Welsh, Bin Fang, Yuliana Hernandez, Trevor Rose, Jhanelle Gray, John Koomen, James Mule

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy

    Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy oleh Chad Pickering, Paul Aiyetan, Gege Xu, Alan Mitchell, Rachel Rice, Yana G. Najjar, Joseph Markowitz, Joseph Markowitz, Lisa M. Ebert, Lisa M. Ebert, Lisa M. Ebert, Michael P. Brown, Michael P. Brown, Michael P. Brown, Gonzalo Tapia-Rico, Dennie Frederick, Xin Cong, Daniel Serie, Klaus Lindpaintner, Flavio Schwarz, Genevieve M. Boland

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Plasma MicroRNA Levels Following Resection of Metastatic Melanoma

    Plasma MicroRNA Levels Following Resection of Metastatic Melanoma oleh Nicholas Latchana, Zachary B Abrams, J Harrison Howard, Kelly Regan, Naduparambil Jacob, Paolo Fadda, Alicia Terando, Joseph Markowitz, Doreen Agnese, Philip Payne, William E Carson

    Diterbitkan 2017-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    797 Significant anti-tumor activity of HBI-8000, a class I histone deacetylase inhibitor (HDACi) in combination with nivolumab (NIVO) in anti-PD1 therapy-naïve advanced melanoma (TN-Mel)

    797 Significant anti-tumor activity of HBI-8000, a class I histone deacetylase inhibitor (HDACi) in combination with nivolumab (NIVO) in anti-PD1 therapy-naïve advanced melanoma (T... oleh Joseph Markowitz, Siqing Fu, Gregory Daniels, Lyudmila Bazhenova, Nikhil Khushalani, Zeynep Eroglu, Andrew Brohl, Heather Yeckes-Rodin, Lori McCormick, Michael Kurman, Mireille Gillings, Gloria Lee

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

    Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma oleh John E. Mullinax, John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey Weber, Nikhil Khushalani, Zeynep Eroglu, Andrew S. Brohl, Andrew S. Brohl, Joseph Markowitz, Joseph Markowitz, Erica Royster, Allison Richards, Valerie Stark, Jonathan S. Zager, Jonathan S. Zager, Linda Kelley, Cheryl Cox, Vernon K. Sondak, James J. Mulé, James J. Mulé, Shari Pilon-Thomas, Shari Pilon-Thomas, Amod A. Sarnaik, Amod A. Sarnaik

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma

    Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma oleh Joseph Markowitz, Ahmad A Tarhini, Zeynep Eroglu, Evan J Wuthrick, Andrew S Brohl, Nikhil I Khushalani, Vernon K Sondak, Lilit Karapetyan, Tanya Ramadoss, Matthew Nichols, Christian Palacios, Kenneth Y Tsai

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    43 Harnessing the power of glycoproteomics: a cutting-edge approach for predicting treatment efficacy in metastatic melanoma with immune checkpoint inhibitors

    43 Harnessing the power of glycoproteomics: a cutting-edge approach for predicting treatment efficacy in metastatic melanoma with immune checkpoint inhibitors oleh Joseph Markowitz, Yana G Najjar, Michael P Brown, Dennie Frederick, Genevieve M Boland, Klaus Lindpaintner, Gege Xu, Rachel Rice, Daniel Serie, Lisa M Ebert, Alan Mitchell, Xin Cong, Gonzalo Tapia-Rico, Chad Pickering, Paul Aiyetan, Ranjan Bhadra, Chirag Dhar, Flavio Schwarz

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    625 Immune priming IFx-Hu2.0 promotes antibody responses necessary for anti-PD1 responses in PD-1 refractory melanoma patients

    625 Immune priming IFx-Hu2.0 promotes antibody responses necessary for anti-PD1 responses in PD-1 refractory melanoma patients oleh Joseph Markowitz, Shari Pilon-Thomas, Amod A Sarnaik, Pei-ling Chen, Ahmad A Tarhini, Zeynep Eroglu, Andrew S Brohl, Nikhil I Khushalani, Vernon K Sondak, Youngchul Kim, Michael Shamblott, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward Garcia, Ashraf Delhawi, Deanryan BDe Aquino, Patricia Lawman

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma

    Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma oleh Judith D Goldberg, Joseph Markowitz, Jeffrey Weber, Ragini Kudchadkar, Tomas Kirchhoff, Anna Pavlick, Zeynep Eroglu, Melinda Vassallo, David M Woods, Andrew S Brohl, Nikhil I Khushalani, Alison Richards, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: